One of the world’s leading investment firms has broken its own record with the closing of its $6.3 billion Blackstone Life ...

Let’s explore the implications of this clinical achievement for Kodiak’s market position, the calculations behind its current ...

By Siddhi Mahatole March 26 (Reuters) - Shares of Kodiak Sciences surged 68.6% to their highest in more than four years on ...

The post-pandemic bubble popped, but life sciences aren’t going anywhere. Blackstone announced Monday that it closed ...

Kodiak Sciences' stock (NASDAQ: KOD) saw a massive 75% breakout yesterday, March 26 2026, pushing the stock to nearly $40 ...

Wave Life Sciences (WVE) stock plunges as the company interim data from an early-stage trial for WVE-007, its RNA-based ...

Kodiak Sciences recently reported positive topline results from its GLOW2 Phase 3 study, where Zenkuda (tarcocimab tedromer) showed superiority to sham in treating a broad range of diabetic ...

Shares of Kodiak Sciences shot higher after the company disclosed what it called positive results from a late-stage study of its treatment for diabetic retinopathy, a progressive disease that occurs ...

Forbes contributors publish independent expert analyses and insights. Bruce Japsen writes about healthcare business and policy. Abbott Laboratories $21 billion deal to acquire cancer test maker Exact ...

Family and consumer sciences professionals shape lives daily, support communities and quietly power some of the country’s most essential industries. For years, the value of that work has been clear to ...